SC 13G/A: UroGen Pharma Ltd.

AI Summary

SC 13G/A filing by UroGen Pharma Ltd..

Risk Assessment

Risk Level: low

Filing Documents

• zk2430968.htm (SC 13G/A) — 95KB
• 0001178913-24-000537.txt ( ) — 97KB

From the Filing

SC 13G/A 1 zk2430968.htm SC 13G/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G UNDER THE SECURITIES EXCHANGE ACT OF 1934 (Amendment No.7)* UroGen Pharma Ltd. (Name of Issuer) Ordinary Shares, par value NIS 0.01 per share (Title of Class of Securities) M96088105 (CUSIP Number) December 31 , 2023 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to designate the rule pursuant to which this Schedule is filed: Rule 13d-1(b) Rule 13d-1(c) Rule 13d-1(d) *The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page. The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes). CUSIP No. M96088105 13G Page 2 of 9 Pages 1 NAMES OF REPORTING PERSONS Menora Mivtachim Holdings Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Israel NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER --- 6 SHARED VOTING POWER 2,303,031 (*) 7 SOLE DISPOSITIVE POWER --- 8 SHARED DISPOSITIVE POWER 2,303,031 (*) 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,303,031 (*) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 7.46% (*) (**) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (*) The beneficial ownership of the securities reported herein is described in Item 4(a). (**) Based on 30,866,000 Ordinary Shares outstanding as of December 31, 2023 (as reported on Bloomberg LP). 2 CUSIP No. M96088105 13G Page 3 of 9 Pages 1 NAMES OF REPORTING PERSONS Menora Mivtachim Pensions and Gemel Ltd. 2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (a) (b) 3 SEC USE ONLY 4 CITIZENSHIP OR PLACE OF ORGANIZATION Israel NUMBER OF SHARES BENEFICIALLY OWNED BY EACH REPORTING PERSON WITH 5 SOLE VOTING POWER --- 6 SHARED VOTING POWER 2,030,563 (*) 7 SOLE DISPOSITIVE POWER --- 8 SHARED DISPOSITIVE POWER 2,030,563 (*) 9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON 2,030,563 (*) 10 CHECK IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES (SEE INSTRUCTIONS) 11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9) 6.58% (*) (**) 12 TYPE OF REPORTING PERSON (SEE INSTRUCTIONS) CO (*) The beneficial ownership of the securities reported herein is described in Item 4(a). (**) Based on 30,866,000 Ordinary Shares outstanding as of December 31, 2023 (as reported on Bloomberg LP). 3 Item 1. (a) Name of Issuer : UroGen Pharma Ltd. (b) Address of Issuer's Principal Executive Offices : 400 Alexander Park, Princeton, New Jersey 08540. Item 2. (a) Name of Person Filing : Menora Mivtachim Holdings Ltd. Menora Mivtachim Pensions and Gemel Ltd. (b) Address of Principal Business Office : Menora Mivtachim Holdings Ltd. – Menora House, 23 Jabotinsky St., Ramat Gan 5251102, Israel Menora Mivtachim Pensions and Gemel Ltd. – Menora House, 23 Jabotinsky St., Ramat Gan 5251102, Israel (c) Citizenship or Place of Incorporation : Menora Mivtachim Holdings Ltd. – Israel Menora Mivtachim Pensions and Gemel Ltd. – Israel (d) Title of Class of Securities : Ordinary Shares, par value NIS 0.01 per share (e) CUSIP Number : M96088105 Item 3 . Not applicable. Item 4 . Ownership : (a) Amount beneficially owned : See row 9 of cover page of each reporting person. 4 As of December 31, 2023, the securities reported herein were beneficially owned as follows: 2,030,563 ordinary shares (representing 6.58% of the total ordinary shares outstanding) beneficially owned by Menora Mivtachim Pensions and Gemel Ltd.; 17,234 ordinary shares (representing 0.06% of the total ordinary shares outstanding) beneficially owned by Menora Mivtachim Vehistadrut Hamehandesim Nihul Kupot Gemel Ltd.; 255,234 ordinary shares (representing 0.83% of the total ordinary shares outstanding) beneficially owned by Menora Mivtachim Insurance Ltd.; The securities reported herein are beneficially owned by Menora Mivtachim Holdings Ltd. ("Menora Holdings") and by entities that are direct or indirect, wholly-owned or majority-owned, subsidiaries of Menora Holdings (the "Subsidiaries"), such as Menora Mivtachim Insurance Ltd., Shomera Insurance Company Ltd., Menora Mivtachim Pensions and Gemel Ltd., Menora Mivtachim Vehistadrut Hamehandesim Nihul Kupot Gemel Ltd. The economic interest or beneficial o